STAT3 and central nervous system cancer: Association with tumor grade and GB recurrence (64).In EGFRvIII-expressing glioma cells, association with increased H3K23ac and recruitment of STAT3 to promote GSC proliferation and oncosphere formation (Figure 1D). Rescue by treatment with EGFR inhibitor erlotinib (65).